+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Companion Diagnostics Market 2024-2028

  • PDF Icon

    Report

  • 177 Pages
  • June 2024
  • Region: Global
  • TechNavio
  • ID: 5232345
1h Free Analyst Time

Market Growth Has Experienced a Change of 25.29% YoY in 2020

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The companion diagnostics market is forecasted to grow by USD 28.98 billion during 2023-2028, accelerating at a CAGR of 36.5% during the forecast period. The report on the companion diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising use of personalized medicine, increased industry collaborations, and growing investments in life sciences sector.

The companion diagnostics market is segmented as below:

By End-user

  • Life science
  • Health centers
  • Others

By Indication

  • Oncology
  • Neurology
  • Others

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising occurrence of breast cancer as one of the prime reasons driving the companion diagnostics market growth during the next few years. Also, increase in product approvals to treat cancer and growing importance for promotional activities will lead to sizable demand in the market.

The report on the companion diagnostics market covers the following areas:

  • Companion diagnostics market sizing
  • Companion diagnostics market forecast
  • Companion diagnostics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading companion diagnostics market vendors that include Abbott Laboratories, Abnova Corp., Agilent Technologies Inc., Amoy Diagnostics Co. Ltd., ARUP Laboratories, Bayer AG, BioGenex Laboratories Inc., bioMerieux SA, F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Invivoscribe Inc., Liquid Biotech USA Inc., Myriad Genetics Inc., NG Biotech, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc. Also, the companion diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Indication
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Companion Diagnostics Market 2018 - 2022
Historic Market Size - Data Table on Global Companion Diagnostics Market 2018 - 2022 ($ million)
4.2 End-user segment analysis 2018 - 2022
Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.3 Indication segment analysis 2018 - 2022
Historic Market Size - Indication Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Chart on End-user - Market share 2023-2028 (%)
Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
6.3 Life science - Market size and forecast 2023-2028
Chart on Life science - Market size and forecast 2023-2028 ($ million)
Data Table on Life science - Market size and forecast 2023-2028 ($ million)
Chart on Life science - Year-over-year growth 2023-2028 (%)
Data Table on Life science - Year-over-year growth 2023-2028 (%)
6.4 Health centers - Market size and forecast 2023-2028
Chart on Health centers - Market size and forecast 2023-2028 ($ million)
Data Table on Health centers - Market size and forecast 2023-2028 ($ million)
Chart on Health centers - Year-over-year growth 2023-2028 (%)
Data Table on Health centers - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Indication
7.1 Market segments
Chart on Indication - Market share 2023-2028 (%)
Data Table on Indication - Market share 2023-2028 (%)
7.2 Comparison by Indication
Chart on Comparison by Indication
Data Table on Comparison by Indication
7.3 Oncology - Market size and forecast 2023-2028
Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Chart on Oncology - Year-over-year growth 2023-2028 (%)
Data Table on Oncology - Year-over-year growth 2023-2028 (%)
7.4 Neurology - Market size and forecast 2023-2028
Chart on Neurology - Market size and forecast 2023-2028 ($ million)
Data Table on Neurology - Market size and forecast 2023-2028 ($ million)
Chart on Neurology - Year-over-year growth 2023-2028 (%)
Data Table on Neurology - Year-over-year growth 2023-2028 (%)
7.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Indication
Market opportunity by Indication ($ million)
Data Table on Market opportunity by Indication ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.11 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Abbott Laboratories
Abbott Laboratories - Overview
Abbott Laboratories - Business segments
Abbott Laboratories - Key news
Abbott Laboratories - Key offerings
Abbott Laboratories - Segment focus
12.4 Abnova Corp.
Abnova Corp. - Overview
Abnova Corp. - Product / Service
Abnova Corp. - Key offerings
12.5 Agilent Technologies Inc.
Agilent Technologies Inc. - Overview
Agilent Technologies Inc. - Business segments
Agilent Technologies Inc. - Key news
Agilent Technologies Inc. - Key offerings
Agilent Technologies Inc. - Segment focus
12.6 Amoy Diagnostics Co. Ltd.
Amoy Diagnostics Co. Ltd. - Overview
Amoy Diagnostics Co. Ltd. - Product / Service
Amoy Diagnostics Co. Ltd. - Key offerings
12.7 ARUP Laboratories
ARUP Laboratories - Overview
ARUP Laboratories - Product / Service
ARUP Laboratories - Key offerings
12.8 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.9 BioGenex Laboratories Inc.
BioGenex Laboratories Inc. - Overview
BioGenex Laboratories Inc. - Product / Service
BioGenex Laboratories Inc. - Key offerings
12.10 bioMerieux SA
bioMerieux SA - Overview
bioMerieux SA - Product / Service
bioMerieux SA - Key news
bioMerieux SA - Key offerings
12.11 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.12 Illumina Inc.
Illumina Inc. - Overview
Illumina Inc. - Business segments
Illumina Inc. - Key news
Illumina Inc. - Key offerings
Illumina Inc. - Segment focus
12.13 Myriad Genetics Inc.
Myriad Genetics Inc. - Overview
Myriad Genetics Inc. - Product / Service
Myriad Genetics Inc. - Key news
Myriad Genetics Inc. - Key offerings
12.14 QIAGEN NV
QIAGEN NV - Overview
QIAGEN NV - Product / Service
QIAGEN NV - Key news
QIAGEN NV - Key offerings
12.15 Siemens AG
Siemens AG - Overview
Siemens AG - Business segments
Siemens AG - Key news
Siemens AG - Key offerings
Siemens AG - Segment focus
12.16 Sysmex Corp.
Sysmex Corp. - Overview
Sysmex Corp. - Business segments
Sysmex Corp. - Key news
Sysmex Corp. - Key offerings
Sysmex Corp. - Segment focus
12.17 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Indication
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Companion Diagnostics Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Indication Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on End-user - Market share 2023-2028 (%)
Exhibits 33: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by End-user
Exhibits 35: Data Table on Comparison by End-user
Exhibits 36: Chart on Life science - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on Life science - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on Life science - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on Life science - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on Health centers - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on Health centers - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on Health centers - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on Health centers - Year-over-year growth 2023-2028 (%)
Exhibits 44: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 45: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 46: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 47: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 48: Market opportunity by End-user ($ million)
Exhibits 49: Data Table on Market opportunity by End-user ($ million)
Exhibits 50: Chart on Indication - Market share 2023-2028 (%)
Exhibits 51: Data Table on Indication - Market share 2023-2028 (%)
Exhibits 52: Chart on Comparison by Indication
Exhibits 53: Data Table on Comparison by Indication
Exhibits 54: Chart on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Oncology - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Oncology - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Neurology - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Neurology - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Neurology - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Neurology - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 66: Market opportunity by Indication ($ million)
Exhibits 67: Data Table on Market opportunity by Indication ($ million)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 109: Market opportunity By Geographical Landscape ($ million)
Exhibits 110: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 111: Impact of drivers and challenges in 2023 and 2028
Exhibits 112: Overview on criticality of inputs and factors of differentiation
Exhibits 113: Overview on factors of disruption
Exhibits 114: Impact of key risks on business
Exhibits 115: Companies covered
Exhibits 116: Matrix on companies position and classification
Exhibits 117: Abbott Laboratories - Overview
Exhibits 118: Abbott Laboratories - Business segments
Exhibits 119: Abbott Laboratories - Key news
Exhibits 120: Abbott Laboratories - Key offerings
Exhibits 121: Abbott Laboratories - Segment focus
Exhibits 122: Abnova Corp. - Overview
Exhibits 123: Abnova Corp. - Product / Service
Exhibits 124: Abnova Corp. - Key offerings
Exhibits 125: Agilent Technologies Inc. - Overview
Exhibits 126: Agilent Technologies Inc. - Business segments
Exhibits 127: Agilent Technologies Inc. - Key news
Exhibits 128: Agilent Technologies Inc. - Key offerings
Exhibits 129: Agilent Technologies Inc. - Segment focus
Exhibits 130: Amoy Diagnostics Co. Ltd. - Overview
Exhibits 131: Amoy Diagnostics Co. Ltd. - Product / Service
Exhibits 132: Amoy Diagnostics Co. Ltd. - Key offerings
Exhibits 133: ARUP Laboratories - Overview
Exhibits 134: ARUP Laboratories - Product / Service
Exhibits 135: ARUP Laboratories - Key offerings
Exhibits 136: Bayer AG - Overview
Exhibits 137: Bayer AG - Business segments
Exhibits 138: Bayer AG - Key news
Exhibits 139: Bayer AG - Key offerings
Exhibits 140: Bayer AG - Segment focus
Exhibits 141: BioGenex Laboratories Inc. - Overview
Exhibits 142: BioGenex Laboratories Inc. - Product / Service
Exhibits 143: BioGenex Laboratories Inc. - Key offerings
Exhibits 144: bioMerieux SA - Overview
Exhibits 145: bioMerieux SA - Product / Service
Exhibits 146: bioMerieux SA - Key news
Exhibits 147: bioMerieux SA - Key offerings
Exhibits 148: F. Hoffmann La Roche Ltd. - Overview
Exhibits 149: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 150: F. Hoffmann La Roche Ltd. - Key news
Exhibits 151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 152: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 153: Illumina Inc. - Overview
Exhibits 154: Illumina Inc. - Business segments
Exhibits 155: Illumina Inc. - Key news
Exhibits 156: Illumina Inc. - Key offerings
Exhibits 157: Illumina Inc. - Segment focus
Exhibits 158: Myriad Genetics Inc. - Overview
Exhibits 159: Myriad Genetics Inc. - Product / Service
Exhibits 160: Myriad Genetics Inc. - Key news
Exhibits 161: Myriad Genetics Inc. - Key offerings
Exhibits 162: QIAGEN NV - Overview
Exhibits 163: QIAGEN NV - Product / Service
Exhibits 164: QIAGEN NV - Key news
Exhibits 165: QIAGEN NV - Key offerings
Exhibits 166: Siemens AG - Overview
Exhibits 167: Siemens AG - Business segments
Exhibits 168: Siemens AG - Key news
Exhibits 169: Siemens AG - Key offerings
Exhibits 170: Siemens AG - Segment focus
Exhibits 171: Sysmex Corp. - Overview
Exhibits 172: Sysmex Corp. - Business segments
Exhibits 173: Sysmex Corp. - Key news
Exhibits 174: Sysmex Corp. - Key offerings
Exhibits 175: Sysmex Corp. - Segment focus
Exhibits 176: Thermo Fisher Scientific Inc. - Overview
Exhibits 177: Thermo Fisher Scientific Inc. - Business segments
Exhibits 178: Thermo Fisher Scientific Inc. - Key news
Exhibits 179: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 180: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 181: Inclusions checklist
Exhibits 182: Exclusions checklist
Exhibits 183: Currency conversion rates for US$
Exhibits 184: Research methodology
Exhibits 185: Information sources
Exhibits 186: Data validation
Exhibits 187: Validation techniques employed for market sizing
Exhibits 188: Data synthesis
Exhibits 189: 360 degree market analysis
Exhibits 190: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global companion diagnostics market: Abbott Laboratories, Abnova Corp., Agilent Technologies Inc., Amoy Diagnostics Co. Ltd., ARUP Laboratories, Bayer AG, BioGenex Laboratories Inc., bioMerieux SA, F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Invivoscribe Inc., Liquid Biotech USA Inc., Myriad Genetics Inc., NG Biotech, QIAGEN NV, Quest Diagnostics Inc., Siemens AG, Sysmex Corp., and Thermo Fisher Scientific Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising occurrence of breast cancer."

According to the report, one of the major drivers for this market is the rising use of personalized medicine.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Abnova Corp.
  • Agilent Technologies Inc.
  • Amoy Diagnostics Co. Ltd.
  • ARUP Laboratories
  • Bayer AG
  • BioGenex Laboratories Inc.
  • bioMerieux SA
  • F. Hoffmann La Roche Ltd.
  • Guardant Health Inc.
  • Illumina Inc.
  • Invivoscribe Inc.
  • Liquid Biotech USA Inc.
  • Myriad Genetics Inc.
  • NG Biotech
  • QIAGEN NV
  • Quest Diagnostics Inc.
  • Siemens AG
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.